Page last updated: 2024-08-21

dronabinol and Emesis

dronabinol has been researched along with Emesis in 147 studies

Research

Studies (147)

TimeframeStudies, this research(%)All Research%
pre-199073 (49.66)18.7374
1990's17 (11.56)18.2507
2000's17 (11.56)29.6817
2010's28 (19.05)24.3611
2020's12 (8.16)2.80

Authors

AuthorsStudies
Allshouse, AA; Chung, JH; Grobman, WA; Haas, DM; Jarlenski, MP; McMillin, GA; Metz, TD; Parry, S; Saade, GR; Silver, RM; Simhan, HN; Smid, MC1
Bilbao, A; Spanagel, R1
Alderman, B; Amano, K; Bouleuc, C; Case, AA; Crawford, GB; Davis, M; de Feo, G; Garsed, J; Hui, D; Mukhopadhyay, S; Sbrana, A; Tanco, K; To, J1
Chebolu, S; Darmani, NA; Henry, DA; Zhong, W1
Xantus, GZ1
Chow, N; Chow, R; Im, J; Lock, M; Sodhi, E; Valdez, C; Zhang, D1
Chang-Douglass, S; Mulvihill, C; Pilling, S1
Abdi, E; Aghmesheh, M; Begbie, S; Briscoe, K; Cheung, Y; Clarke, S; Della-Fiorentina, S; Fox, P; Gedye, C; Grimison, P; Haber, P; Hahn, C; Kirby, A; Lintzeris, N; McGregor, I; Mersiades, A; Morton, R; Olver, I; Shannon, J; Simes, J; Stockler, M; Tognela, A; Walsh, A1
Hesketh, P; Warr, D1
Bhattacharyya, S; McGoohan, KL; Velayudhan, L1
Biank, V; Black, E; Cordova, J; Leikin, J1
Earl, V; Howell, M; Malik, M; Rosenthal, J1
Häuser, W; Krcevski-Skvarc, N; Wells, C1
Chacko, B; Rajkumar, T1
Hayes, MW; Kunchok, A; Spring, PJ1
Adeagbo, B; Gofton, J; Jones, G; Miller, A; Nourbakhsh, M1
Dupuis, LL; Jupp, J; Khanna, M; MacDonald, T; Ning, W; Patel, P; Polito, S; Romanick, M; Sung, L; Vennettilli, A; Wiernikowski, J1
Aghmesheh, M; Allsop, DJ; Briscoe, K; Clarke, S; Fox, P; Gedye, C; Grimison, P; Haber, PS; Hahn, C; Kirby, AC; Lintzeris, N; McGregor, I; Mersiades, AJ; Morton, RL; Olver, I; Simes, J; Stockler, M; Tognela, A; Walsh, A; Wong, N1
Wick, JY1
Bigelow, GE; Cone, EJ; Flegel, R; Hayes, E; Mitchell, JM; Schlienz, NJ; Spindle, TR; Vandrey, R1
Allen, D1
Blohm, E; Neavyn, M; Sell, P1
Florek, E; Piekoszewski, W; Tkaczyk, M1
Kopstick, RL; Limebeer, CL; Parker, LA; Rock, EM1
Hernandez, SL; Sheyner, I; Stewart, JT; Stover, KT1
Brar, RS; Chebolu, S; Darmani, NA; McClanahan, B; Trinh, C; Zhong, W1
Bonnet, U; Isbruch, K; Stratmann, U1
Hill, KP1
Frost, DW; Lam, PW1
Bugaj, B; Cabała, K; Pypno, D; Waracki, M; Zdrojewicz, Z1
Parker, LA; Rock, EM1
Bayman, L; Reichenbach, ZW; Rizvi-Toner, A; Schey, R; Sloan, J; Valestin, J1
Bajgoric, S; Chandrapalan, S; Gautam, N; Samra, K1
Ciccone, CD1
Goyal, H; Gupta, U; May, E; Singla, U1
LeQuang, JA; Pergolizzi, JV; Raffa, RB; Taylor, R; Zampogna, G1
Darmani, NA; Griggs, L; Ray, AP1
Darmani, NA; McClanahan, BA; Ray, AP; Wang, Y1
Cluny, NL; Javid, FA; Naylor, RJ; Whittle, BA1
Aguilar-Urbano, VM; Navarro-Jarabo, JM; Pérez-Aisa, Á; Sánchez-Cantos, A1
Abanades, S; Arriola, E; Capellà, D; Duran, M; Farré, M; Laporte, JR; Majem, M; Pastor, A; Pérez, E; Rabanal, M; Rams, N; Saura, C; Vidal, X1
Bramstedt, J; Dissmann, R1
Todaro, B1
Hennemann, A1
Breivogel, CS; Crim, JL; Darmani, NA; Janoyan, JJ; Martin, BR; Parekh, B; Sim-Selley, LJ1
Davison, JS; Mackie, K; Oland, LD; Sharkey, KA; Van Sickle, MD1
Burton, P; Kwiatkowska, M; Mechoulam, R; Parker, LA2
Crim, JL; Darmani, NA1
Kwiatkowska, M; Parker, LA1
Daeninck, P; Davis, M; Maida, V; Pergolizzi, J1
Baranowski, V; Barbato, LM; Carter, FJ; Jhangiani, H; Meiri, E; Vredenburgh, JJ; Yang, HM1
Crim, J; Darmani, NA; Janoyan, JJ; Ramirez, J1
Davis, MP1
Egan, EL; Fallon, SD; Niamatali, C1
Fiore, JJ; Gralla, RJ1
Bakowski, MT1
Rose, M1
Gabryś, K; Kotlarek-Haus, S; Orzechowska-Juzwenko, K1
Laszlo, J; Lucas, VS1
Sweet, DL1
Buchanan-Davidson, DJ; Earhart, RH1
Chang, AE; Rosenberg, SA; Seipp, CA; Shiling, DJ1
Bolton, A; de Pemberton, R; Whitehouse, JM; Williams, CJ1
Bloome, B; McKernan, JF; Orr, LE1
Baker, JJ; Lokey, JL; Price, NA; Winokur, SH1
Barofsky, I; Chang, AE; Goldberg, NH; Rosenberg, SA; Seipp, CA; Shiling, DJ; Stillman, RC1
Cato, AE; Cocchetto, DM; Cook, LF1
Stark, P2
Aapro, MS1
Macek, C1
Baggerman, C1
Andrysiak, T; Fairbanks, L; Goodnight, J; Jamison, K; Sarna, G; Ungerleider, JT1
Miller, NJ; Sweet, DL; Weddington, WW1
Joranson, DE; Treffert, DA1
Groenroos, M; Johansson, R; Kilkku, P1
Laszlo, J1
Bogdon, DL; Gota, CH; Gunnell, JC; Hum, GJ; Rieth, TE; Wada, JK1
Durant, JR; Greco, FA; Jones, SE; Robertone, A1
Levitt, M1
Einhorn, L1
Cone, LA; Greene, DS; Helm, NA1
Hollister, LE1
Mooney, CA; Smith, IE; Stuart-Harris, RC1
Ahmedzai, S; Calder, IT; Carlyle, DL; Moran, F1
Andrysiak, TA; Fairbanks, LA; Parker, RG; Tesler, AS; Ungerleider, JT1
Biran, S; Edelstein, E; Fuks, Z; Gez, E; Lander, N; Mechoulam, R1
Priestman, SG; Priestman, TJ1
Beveridge, RA; Schwartz, RH1
Doblin, R; Kleiman, MA2
Doyle, E; Spence, AA1
Strunin, L; Toner, CC1
Barrowcliffe, MP; Campbell, DN; Lewis, IH1
Gilbert, CJ; Ohly, KV; Peters, WP; Rosner, G1
Mathre, ML1
Gonzalez-Rosales, F; Walsh, D1
Lange, RC; McCallum, RW; Plankey, MW; Ricci, DA; Soykan, I; Sridhar, KR1
Mechoulam, R1
Darmani, NA1
Bruntsch, U1
Ekert, H; Jurk, IH; Loughnan, P; Mobilia, J; Waters, KD1
Barofsky, I; Chang, AE; Goldberg, NH; Rosenberg, SA; Seipp, CA; Shiling, DJ; Simon, RM; Stillman, RC1
Chester, AB; Dean, JC; Dorr, RT; Einhorn, LH; Furnas, B; Herman, TS; Jones, SE; Leigh, SA; Moon, TE; Nagy, C; Williams, SD1
Buyniski, JP; Doran, KM; Gylys, JA1
Bedell, SE1
Borison, HL; London, SW; McCarthy, LE2
Creagan, ET; Frytak, S; Moertel, CG; O'Connell, MJ; O'Fallon, JR; Rubin, J; Schutt, AJ; Schwartau, NW1
Bhargava, HN1
Cohen, S1
Sulkowski, A; Vachon, L1
Frei, E; Sallan, SE; Zinberg, NE1
Caswell, A1
Flynn, J; Hanif, N1
Ferguson, J; Hamm, J; Hammill, S; Holroyde, CP; Krasnow, S; Lane, M; Saiers, JL; Salva, K; Vogel, CL; Wiernik, PH1
Gorter, RW; Krasnow, SH; Lane, M; Plasse, TF; Shepard, KV; Wadleigh, RG1
Lane, M; Plasse, TF; Smith, FE; Sullivan, RA1
Hutcheson, JR; Sacks, N; Watts, JM; Webb, RE1
Burks, TF; Shook, JE1
Goldberg, DJ; Green, ST; Kennedy, DH; Nathwani, D1
Feigenbaum, JJ; Mechoulam, R; Richmond, SA; Weissman, Y1
Devine, ML; Dow, GJ; Greenberg, BR; Holstein, DW; Icaza, L; Jue, PY; Meyers, FH; O'Brien, E; Roberts, CM; Rocchio, GL1
Adams, L; Bradley, CJ; Cunningham, D; Forrest, GJ; Harding, M; Hutcheon, AW; Kaye, SB; Kerr, DJ; Sneddon, M; Soukop, M1
Manzo, M1
Citron, ML; Cohen, MH; Fossieck, BE; Franklin, R; Harwood, S; Herman, TS; Krasnow, SH; Vreeland, F1
Andrysiak, T; Ungerleider, JT1
Donovan, A1
Calder, IT; Cunningham, D; Forrest, GJ; Gilchrist, NL; McArdle, CS; Soukop, M1
Ames, FR; Cridland, JS1
Mattson, K; Niiranen, A2
Murakami, M; Ota, K1
Niederle, N; Schmidt, CG; Schütte, J1
Bartlett, H; Dalzell, AM; Lilleyman, JS1
Fennelly, JJ; Pomeroy, M; Towers, M1
Roffman, RA1
Chan, HS; Correia, JA; MacLeod, SM1

Reviews

25 review(s) available for dronabinol and Emesis

ArticleYear
Medical cannabinoids: a pharmacology-based systematic review and meta-analysis for all relevant medical indications.
    BMC medicine, 2022, 08-19, Volume: 20, Issue:1

    Topics: Cannabinoids; Chronic Pain; Dronabinol; Humans; Nausea; Vomiting

2022
Multinational Association of Supportive Care in Cancer (MASCC) expert opinion/consensus guidance on the use of cannabinoids for gastrointestinal symptoms in patients with cancer.
    Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2022, Dec-16, Volume: 31, Issue:1

    Topics: Adult; Anorexia; Antiemetics; Antineoplastic Agents; Cachexia; Cannabinoids; Cannabis; Consensus; Dronabinol; Expert Testimony; Humans; Nausea; Neoplasms; Randomized Controlled Trials as Topic; Vomiting

2022
Vaping-associated lung injury-VALI facts, assumptions and opportunities: review of the present situation.
    Postgraduate medical journal, 2020, Volume: 96, Issue:1132

    Topics: Diarrhea; Dronabinol; Electronic Nicotine Delivery Systems; Glycerol; Humans; Lung Injury; Nicotine; Oils; Propylene Glycol; Respiratory Distress Syndrome; Vaping; Vomiting

2020
Oral cannabinoid for the prophylaxis of chemotherapy-induced nausea and vomiting-a systematic review and meta-analysis.
    Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2020, Volume: 28, Issue:5

    Topics: Adult; Antiemetics; Antineoplastic Agents; Cannabinoids; Dronabinol; Humans; Induction Chemotherapy; Nausea; Neoplasms; Receptor, Cannabinoid, CB2; Vomiting

2020
Evaluation of THC-Related Neuropsychiatric Symptoms Among Adults Aged 50 Years and Older: A Systematic Review and Metaregression Analysis.
    JAMA network open, 2021, 02-01, Volume: 4, Issue:2

    Topics: Aged; Anorexia; Antineoplastic Agents; Cancer Pain; Cannabidiol; Cannabinoid Receptor Agonists; Cannabinoids; Dizziness; Dose-Response Relationship, Drug; Dronabinol; Humans; Middle Aged; Multiple Sclerosis; Nausea; Neurodegenerative Diseases; Pain; Perceptual Disorders; Randomized Controlled Trials as Topic; Regression Analysis; Self Report; Vomiting

2021
Cannabinoid toxicity in pediatrics.
    Current opinion in pediatrics, 2019, Volume: 31, Issue:2

    Topics: Adolescent; Cannabinoids; Cannabis; Child; Child, Preschool; Dronabinol; Humans; Pediatrics; United States; Vomiting

2019
[Marihuana and cannobinoids as medicaments].
    Przeglad lekarski, 2012, Volume: 69, Issue:10

    Topics: Arthritis, Rheumatoid; Cannabidiol; Cannabinoids; Cannabis; Contraindications; Dronabinol; Drug Combinations; Humans; Inflammatory Bowel Diseases; Multiple Sclerosis; Muscle Spasticity; Nausea; Nervous System Diseases; Pain; Plant Extracts; Vomiting

2012
Medical marijuana: more questions than answers.
    Journal of psychiatric practice, 2014, Volume: 20, Issue:5

    Topics: Antiemetics; District of Columbia; Dronabinol; Humans; Medical Marijuana; Nausea; Psychiatry; United States; Vomiting; Wasting Syndrome

2014
[Potential applications of marijuana and cannabinoids in medicine].
    Polski merkuriusz lekarski : organ Polskiego Towarzystwa Lekarskiego, 2014, Volume: 37, Issue:220

    Topics: Cannabinoids; Diabetes Mellitus; Dronabinol; Humans; Medical Marijuana; Neoplasms; Nervous System Diseases; Pain; Phytotherapy; Receptors, Cannabinoid; Vomiting

2014
Cannabinoid hyperemesis syndrome: a guide for the practising clinician.
    BMJ case reports, 2015, Dec-23, Volume: 2015

    Topics: Adult; Antiemetics; Cannabinoids; Cannabis; Disease Management; Dronabinol; Humans; Male; Marijuana Abuse; Metoclopramide; Nausea; Receptors, Cannabinoid; Syndrome; Vomiting; Young Adult

2015
Medical Marijuana: Just the Beginning of a Long, Strange Trip?
    Physical therapy, 2017, 02-01, Volume: 97, Issue:2

    Topics: Cannabidiol; Cognition Disorders; Confusion; Controlled Substances; Depression; Dronabinol; Drug Administration Routes; Hallucinations; Heart; Humans; Lung; Marijuana Abuse; Medical Marijuana; Memory Disorders; Muscle Spasticity; Nausea; Pain; Physical Therapists; Postural Balance; Professional Role; Vomiting

2017
Role of cannabis in digestive disorders.
    European journal of gastroenterology & hepatology, 2017, Volume: 29, Issue:2

    Topics: Abdominal Pain; Anorexia; Cannabis; Digestive System Diseases; Dronabinol; Endocannabinoids; Gastrointestinal Diseases; Gastrointestinal Motility; Humans; Inflammatory Bowel Diseases; Irritable Bowel Syndrome; Liver Cirrhosis; Medical Marijuana; Nausea; Pancreatic Diseases; Receptors, Cannabinoid; Vomiting

2017
Concise review of the management of iatrogenic emesis using cannabinoids: emphasis on nabilone for chemotherapy-induced nausea and vomiting.
    Cancer chemotherapy and pharmacology, 2017, Volume: 79, Issue:3

    Topics: Antiemetics; Antineoplastic Agents; Cannabinoids; Cannabis; Dronabinol; Humans; Iatrogenic Disease; Randomized Controlled Trials as Topic; Vomiting

2017
Cannabinoids in the treatment of chemotherapy-induced nausea and vomiting.
    Journal of the National Comprehensive Cancer Network : JNCCN, 2012, Volume: 10, Issue:4

    Topics: Antiemetics; Antineoplastic Agents; Cannabinoids; Dronabinol; Humans; Nausea; Vomiting

2012
The emerging role of cannabinoid neuromodulators in symptom management.
    Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2007, Volume: 15, Issue:1

    Topics: Administration, Oral; Analgesics, Non-Narcotic; Antiemetics; Antineoplastic Agents; Breast Neoplasms; Dronabinol; Female; Humans; Middle Aged; Pain; Receptors, Cannabinoid; Spinal Neoplasms; Vomiting

2007
Nabilone (Cesamet) for chemotherapy-induced nausea and vomiting.
    The Medical letter on drugs and therapeutics, 2006, Dec-04, Volume: 48, Issue:1249/1250

    Topics: Antineoplastic Agents; Dronabinol; Humans; Nausea; Vomiting

2006
Oral nabilone capsules in the treatment of chemotherapy-induced nausea and vomiting and pain.
    Expert opinion on investigational drugs, 2008, Volume: 17, Issue:1

    Topics: Administration, Oral; Analgesics, Non-Narcotic; Antiemetics; Antineoplastic Agents; Clinical Trials as Topic; Dronabinol; Humans; Nausea; Pain; Treatment Outcome; Vomiting

2008
Pharmacologic treatment of chemotherapy-induced nausea and vomiting.
    Cancer investigation, 1984, Volume: 2, Issue:5

    Topics: Adrenal Cortex Hormones; Antiemetics; Antineoplastic Agents; Butyrophenones; Chemoreceptor Cells; Dronabinol; Drug Therapy, Combination; Humans; Metoclopramide; Nausea; Phencyclidine; Phenothiazines; Vomiting

1984
Advances in anti-emetic therapy.
    Cancer treatment reviews, 1984, Volume: 11, Issue:3

    Topics: Antiemetics; Antineoplastic Agents; Chemoreceptor Cells; Clinical Trials as Topic; Dexamethasone; Domperidone; Dronabinol; Humans; Metoclopramide; Nausea; Prochlorperazine; Random Allocation; Receptors, Neurotransmitter; Vomiting

1984
A critical review of the safety and antiemetic efficacy of delta-9-tetrahydrocannabinol.
    Drug intelligence & clinical pharmacy, 1981, Volume: 15, Issue:11

    Topics: Animals; Antiemetics; Dronabinol; History, 19th Century; History, 20th Century; History, Ancient; Humans; Neoplasms; Vomiting

1981
Prevention of chemotherapy-induced nausea and vomiting in patients with cancer.
    Arizona medicine, 1981, Volume: 38, Issue:11

    Topics: Antiemetics; Antineoplastic Agents; Dronabinol; Humans; Nausea; Neoplasms; Vomiting

1981
Treatment of nausea and vomiting caused by cancer chemotherapy.
    Cancer treatment reviews, 1982, Volume: 9 Suppl B

    Topics: Antiemetics; Antineoplastic Agents; Cannabinoids; Dronabinol; Humans; Metoclopramide; Nausea; Vomiting

1982
Recent advantages in cannabinoid research.
    Forschende Komplementarmedizin, 1999, Volume: 6 Suppl 3

    Topics: Acquired Immunodeficiency Syndrome; Antiemetics; Antineoplastic Agents; Appetite Stimulants; Cannabinoids; Dronabinol; Humans; Marijuana Smoking; Neoplasms; Receptors, Cannabinoid; Receptors, Drug; Vomiting

1999
Recent clinical experience with dronabinol.
    Pharmacology, biochemistry, and behavior, 1991, Volume: 40, Issue:3

    Topics: Antineoplastic Agents; Appetite; Dronabinol; HIV Infections; Humans; Vomiting

1991
[Recent advances in the management of chemotherapy-induced emesis].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1986, Volume: 13, Issue:3 Pt 1

    Topics: Antiemetics; Antineoplastic Agents; Cisplatin; Dexamethasone; Domperidone; Dronabinol; Drug Therapy, Combination; Haloperidol; Humans; Metoclopramide; Nausea; Neoplasms; Prochlorperazine; Vomiting

1986

Trials

44 trial(s) available for dronabinol and Emesis

ArticleYear
Oral THC:CBD cannabis extract for refractory chemotherapy-induced nausea and vomiting: a randomised, placebo-controlled, phase II crossover trial.
    Annals of oncology : official journal of the European Society for Medical Oncology, 2020, Volume: 31, Issue:11

    Topics: Adult; Aged; Aged, 80 and over; Antiemetics; Antineoplastic Agents; Australia; Cannabidiol; Cannabis; Cross-Over Studies; Double-Blind Method; Dronabinol; Drug Combinations; Female; Humans; Male; Middle Aged; Nausea; Plant Extracts; Vomiting

2020
Safety and efficacy of nabilone for acute chemotherapy-induced vomiting prophylaxis in pediatric patients: A multicenter, retrospective review.
    Pediatric blood & cancer, 2018, Volume: 65, Issue:12

    Topics: Adolescent; Antineoplastic Agents; Child; Child, Preschool; Dronabinol; Female; Humans; Infant; Male; Nausea; Neoplasms; Retrospective Studies; Vomiting

2018
Oral cannabinoid-rich THC/CBD cannabis extract for secondary prevention of chemotherapy-induced nausea and vomiting: a study protocol for a pilot and definitive randomised double-blind placebo-controlled trial (CannabisCINV).
    BMJ open, 2018, 09-12, Volume: 8, Issue:9

    Topics: Administration, Oral; Antineoplastic Agents; Cannabidiol; Cannabinoid Receptor Agonists; Cost-Benefit Analysis; Double-Blind Method; Dronabinol; Drug Combinations; Humans; Multicenter Studies as Topic; Nausea; Patient Reported Outcome Measures; Phytotherapy; Pilot Projects; Randomized Controlled Trials as Topic; Secondary Prevention; Vomiting

2018
A 4-week pilot study with the cannabinoid receptor agonist dronabinol and its effect on metabolic parameters in a randomized trial.
    Clinical therapeutics, 2015, Oct-01, Volume: 37, Issue:10

    Topics: Adult; Aged; Body Mass Index; C-Reactive Protein; Cannabinoid Receptor Agonists; Chest Pain; Double-Blind Method; Dronabinol; Female; Humans; Male; Middle Aged; Nausea; Pilot Projects; Time Factors; Vomiting

2015
Preliminary efficacy and safety of an oromucosal standardized cannabis extract in chemotherapy-induced nausea and vomiting.
    British journal of clinical pharmacology, 2010, Volume: 70, Issue:5

    Topics: Administration, Oral; Adult; Aged; Antiemetics; Antineoplastic Agents; Cannabidiol; Dose-Response Relationship, Drug; Double-Blind Method; Dronabinol; Female; Humans; Male; Middle Aged; Nausea; Pilot Projects; Vomiting

2010
Efficacy of dronabinol alone and in combination with ondansetron versus ondansetron alone for delayed chemotherapy-induced nausea and vomiting.
    Current medical research and opinion, 2007, Volume: 23, Issue:3

    Topics: Adolescent; Adult; Analysis of Variance; Antineoplastic Combined Chemotherapy Protocols; Dose-Response Relationship, Drug; Double-Blind Method; Dronabinol; Drug Administration Schedule; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Male; Middle Aged; Nausea; Neoplasms; Ondansetron; Probability; Reference Values; Risk Assessment; Treatment Outcome; Vomiting

2007
Advances in anti-emetic therapy.
    Cancer treatment reviews, 1984, Volume: 11, Issue:3

    Topics: Antiemetics; Antineoplastic Agents; Chemoreceptor Cells; Clinical Trials as Topic; Dexamethasone; Domperidone; Dronabinol; Humans; Metoclopramide; Nausea; Prochlorperazine; Random Allocation; Receptors, Neurotransmitter; Vomiting

1984
In search of an effective antiemetic: a nusring staff participates in marijuana research.
    Cancer nursing, 1980, Volume: 3, Issue:4

    Topics: Adult; Antiemetics; Attitude of Health Personnel; Clinical Trials as Topic; Double-Blind Method; Dronabinol; Humans; Methotrexate; Nausea; Nurses; Osteosarcoma; Random Allocation; Vomiting

1980
A cannabis dilemma.
    South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde, 1980, May-24, Volume: 57, Issue:21

    Topics: Clinical Trials as Topic; Double-Blind Method; Dronabinol; Humans; Neoplasms; Vomiting

1980
Antiemetics for patients treated with antitumor chemotherapy.
    Cancer clinical trials, 1980, Volume: 3, Issue:4

    Topics: Adolescent; Adult; Aged; Antiemetics; Cisplatin; Cyclizine; Dronabinol; Drug Therapy, Combination; Female; Humans; Male; Metoclopramide; Middle Aged; Nausea; Neoplasms; Pilot Projects; Vomiting

1980
Antiemetic effect of tetrahydrocannabinol. Compared with placebo and prochlorperazine in chemotherapy-associated nausea and emesis.
    Archives of internal medicine, 1980, Volume: 140, Issue:11

    Topics: Adult; Aged; Antineoplastic Agents; Double-Blind Method; Dronabinol; Female; Humans; Male; Middle Aged; Nausea; Neoplasms; Placebos; Prochlorperazine; Vomiting

1980
A prospective evaluation of delta-9-tetrahydrocannabinol as an antiemetic in patients receiving adriamycin and cytoxan chemotherapy.
    Cancer, 1981, Apr-01, Volume: 47, Issue:7

    Topics: Adolescent; Adult; Antiemetics; Clinical Trials as Topic; Cyclophosphamide; Double-Blind Method; Doxorubicin; Dronabinol; Female; Humans; Male; Middle Aged; Nausea; Surveys and Questionnaires; Vomiting

1981
THC: "transitional drug' for emesis therapy?
    JAMA, 1982, May-21, Volume: 247, Issue:19

    Topics: Adult; Animals; Antiemetics; Cannabinoids; Cannabis; Clinical Trials as Topic; Dogs; Dronabinol; Humans; Vomiting

1982
Cannabis and cancer chemotherapy: a comparison of oral delta-9-THC and prochlorperazine.
    Cancer, 1982, Aug-15, Volume: 50, Issue:4

    Topics: Adolescent; Adult; Age Factors; Aged; Analysis of Variance; Antineoplastic Agents; Clinical Trials as Topic; Dronabinol; Drug Administration Schedule; Humans; Middle Aged; Nausea; Neoplasms; Prochlorperazine; Random Allocation; Vomiting

1982
A double-blind, controlled trial of nabilone vs. prochlorperazine for refractory emesis induced by cancer chemotherapy.
    Cancer treatment reviews, 1982, Volume: 9 Suppl B

    Topics: Adolescent; Adult; Aged; Antiemetics; Antineoplastic Agents; Clinical Trials as Topic; Double-Blind Method; Dronabinol; Female; Humans; Male; Middle Aged; Prochlorperazine; Vomiting

1982
Study design for the evaluation of the efficacy and safety of nabilone.
    Cancer treatment reviews, 1982, Volume: 9 Suppl B

    Topics: Antiemetics; Antineoplastic Agents; Clinical Trials as Topic; Double-Blind Method; Dronabinol; Humans; Research Design; Vomiting

1982
Double-blind, randomized, crossover trial of nabilone vs. placebo in cancer chemotherapy.
    Cancer treatment reviews, 1982, Volume: 9 Suppl B

    Topics: Adolescent; Adult; Aged; Aging; Antiemetics; Antineoplastic Agents; Clinical Trials as Topic; Double-Blind Method; Dronabinol; Female; Humans; Male; Middle Aged; Placebos; Sex Factors; Vomiting

1982
A multi-institutional Phase III study of nabilone vs. placebo in chemotherapy-induced nausea and vomiting.
    Cancer treatment reviews, 1982, Volume: 9 Suppl B

    Topics: Adult; Antiemetics; Antineoplastic Agents; Clinical Trials as Topic; Dronabinol; Female; Humans; Male; Middle Aged; Nausea; Placebos; Vomiting

1982
Nabilone vs. placebo in the treatment of chemotherapy-induced nausea and vomiting in cancer patients.
    Cancer treatment reviews, 1982, Volume: 9 Suppl B

    Topics: Adolescent; Adult; Age Factors; Aged; Antiemetics; Antineoplastic Agents; Clinical Trials as Topic; Double-Blind Method; Dronabinol; Female; Humans; Male; Middle Aged; Nausea; Placebos; Vomiting

1982
Anti-emetic efficacy and toxicity of nabilone, a synthetic cannabinoid, in lung cancer chemotherapy.
    British journal of cancer, 1983, Volume: 48, Issue:5

    Topics: Adult; Aged; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Clinical Trials as Topic; Dizziness; Double-Blind Method; Dronabinol; Female; Humans; Lung Neoplasms; Male; Middle Aged; Nausea; Prochlorperazine; Sleep Stages; Vomiting

1983
Tetrahydrocannabinol vs. prochlorperazine. The effects of two antiemetics on patients undergoing radiotherapy.
    Radiology, 1984, Volume: 150, Issue:2

    Topics: Adolescent; Adult; Antiemetics; Clinical Trials as Topic; Double-Blind Method; Dronabinol; Emotions; Humans; Middle Aged; Nausea; Prochlorperazine; Radiotherapy; Vomiting

1984
Nabilone and high-dose metoclopramide: anti-emetics for cancer chemotherapy.
    Drug and therapeutics bulletin, 1984, Feb-10, Volume: 22, Issue:3

    Topics: Antiemetics; Antineoplastic Agents; Clinical Trials as Topic; Double-Blind Method; Dronabinol; Humans; Metoclopramide; Nausea; Vomiting

1984
Effect of nabilone on nausea and vomiting after total abdominal hysterectomy.
    British journal of anaesthesia, 1994, Volume: 73, Issue:2

    Topics: Adult; Aged; Antiemetics; Double-Blind Method; Dronabinol; Drug Administration Schedule; Female; Humans; Hysterectomy; Metoclopramide; Middle Aged; Nausea; Postoperative Complications; Premedication; Prospective Studies; Vomiting

1994
Randomized, double-blind comparison of a prochlorperazine-based versus a metoclopramide-based antiemetic regimen in patients undergoing autologous bone marrow transplantation.
    Cancer, 1995, Dec-01, Volume: 76, Issue:11

    Topics: Adult; Antiemetics; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Carmustine; Cisplatin; Clinical Protocols; Cyclophosphamide; Diphenhydramine; Double-Blind Method; Dronabinol; Female; Humans; Injections, Intravenous; Lorazepam; Male; Metoclopramide; Middle Aged; Nausea; Placebos; Prochlorperazine; Transplantation, Autologous; Vomiting

1995
Delta-9-tetrahydrocannabinol delays the gastric emptying of solid food in humans: a double-blind, randomized study.
    Alimentary pharmacology & therapeutics, 1999, Volume: 13, Issue:1

    Topics: Adult; Antiemetics; Double-Blind Method; Dronabinol; Female; Food; Gastric Emptying; Humans; Male; Nausea; Radiopharmaceuticals; Reference Values; Technetium; Time Factors; Vomiting

1999
Nausea and vomiting associated with HIV therapy are reduced with Marinol.
    The AIDS reader, 2000, Volume: 10, Issue:12

    Topics: Analgesics, Non-Narcotic; Anti-HIV Agents; Dronabinol; HIV Infections; Humans; Nausea; Treatment Outcome; Vomiting

2000
Amelioration of cancer chemotherapy-induced nausea and vomiting by delta-9-tetrahydrocannabinol.
    The Medical journal of Australia, 1979, Dec-15, Volume: 2, Issue:12

    Topics: Antiemetics; Antineoplastic Agents; Child; Clinical Trials as Topic; Double-Blind Method; Dronabinol; Humans; Metoclopramide; Nausea; Prochlorperazine; Vomiting

1979
Delata-9-tetrahydrocannabinol as an antiemetic in cancer patients receiving high-dose methotrexate. A prospective, randomized evaluation.
    Annals of internal medicine, 1979, Volume: 91, Issue:6

    Topics: Adolescent; Adult; Antiemetics; Double-Blind Method; Dronabinol; Drug Evaluation; Female; Humans; Male; Methotrexate; Middle Aged; Nausea; Osteosarcoma; Placebos; Prospective Studies; Vomiting

1979
Superiority of nabilone over prochlorperazine as an antiemetic in patients receiving cancer chemotherapy.
    The New England journal of medicine, 1979, Jun-07, Volume: 300, Issue:23

    Topics: Adolescent; Adult; Aged; Antiemetics; Antineoplastic Agents; Clinical Trials as Topic; Dronabinol; Drug Evaluation; Female; Humans; Male; Middle Aged; Neoplasms; Prochlorperazine; Vomiting

1979
Delta-9-tetrahydrocannabinol as an antiemetic for patients receiving cancer chemotherapy. A comparison with prochlorperazine and a placebo.
    Annals of internal medicine, 1979, Volume: 91, Issue:6

    Topics: Adult; Aged; Antiemetics; Double-Blind Method; Dronabinol; Drug Evaluation; Fluorouracil; Gastrointestinal Neoplasms; Humans; Middle Aged; Nausea; Nitrosourea Compounds; Placebos; Prochlorperazine; Semustine; Vomiting

1979
Antiemetic effect of delta-9-tetrahydrocannabinol in patients receiving cancer chemotherapy.
    The New England journal of medicine, 1975, Oct-16, Volume: 293, Issue:16

    Topics: Administration, Oral; Adolescent; Adult; Aged; Antiemetics; Antineoplastic Agents; Cannabis; Clinical Trials as Topic; Dronabinol; Female; Humans; Male; Middle Aged; Neoplasms; Phytotherapy; Vomiting

1975
Dronabinol and prochlorperazine in combination for treatment of cancer chemotherapy-induced nausea and vomiting.
    Journal of pain and symptom management, 1991, Volume: 6, Issue:6

    Topics: Adult; Aged; Antineoplastic Agents; Double-Blind Method; Dronabinol; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Nausea; Prochlorperazine; Vomiting

1991
Dronabinol and prochlorperazine alone and in combination as antiemetic agents for cancer chemotherapy.
    American journal of clinical oncology, 1990, Volume: 13, Issue:6

    Topics: Adult; Antineoplastic Agents; Double-Blind Method; Dronabinol; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Nausea; Prochlorperazine; Vomiting

1990
Adverse reactions to delta-9-tetrahydrocannabinol given as an antiemetic in a multicenter study.
    Clinical pharmacy, 1987, Volume: 6, Issue:4

    Topics: Adult; Antiemetics; Antineoplastic Agents; Clinical Trials as Topic; Dronabinol; Drug Evaluation; Female; Humans; Male; Middle Aged; Nausea; Vomiting

1987
A randomized trial of oral nabilone and prochlorperazine compared to intravenous metoclopramide and dexamethasone in the treatment of nausea and vomiting induced by chemotherapy regimens containing cisplatin or cisplatin analogues.
    European journal of cancer & clinical oncology, 1988, Volume: 24, Issue:4

    Topics: Adolescent; Adult; Aged; Antiemetics; Cisplatin; Clinical Trials as Topic; Dexamethasone; Dronabinol; Drug Therapy, Combination; Female; Humans; Male; Metoclopramide; Middle Aged; Nausea; Neoplasms; Prochlorperazine; Random Allocation; Vomiting

1988
Antiemetic efficacy of levonantradol compared to delta-9-tetrahydrocannabinol for chemotherapy-induced nausea and vomiting.
    Cancer treatment reports, 1985, Volume: 69, Issue:1

    Topics: Adult; Aged; Antineoplastic Agents; Clinical Trials as Topic; Double-Blind Method; Dronabinol; Humans; Middle Aged; Nausea; Neoplasms; Phenanthridines; Random Allocation; Vomiting

1985
Nabilone and prochlorperazine: a useful combination for emesis induced by cytotoxic drugs.
    British medical journal (Clinical research ed.), 1985, Sep-28, Volume: 291, Issue:6499

    Topics: Adult; Aged; Antiemetics; Antineoplastic Agents; Clinical Trials as Topic; Double-Blind Method; Dronabinol; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Prochlorperazine; Vomiting

1985
A cross-over comparison of nabilone and prochlorperazine for emesis induced by cancer chemotherapy.
    American journal of clinical oncology, 1985, Volume: 8, Issue:4

    Topics: Administration, Oral; Aged; Antineoplastic Combined Chemotherapy Protocols; Appetite; Blood Pressure; Clinical Trials as Topic; Double-Blind Method; Dronabinol; Drug Evaluation; Female; Humans; Lung Neoplasms; Male; Middle Aged; Nausea; Prochlorperazine; Random Allocation; Vomiting

1985
Crossover comparison of the antiemetic efficacy of nabilone and alizapride in patients with nonseminomatous testicular cancer receiving cisplatin therapy.
    Klinische Wochenschrift, 1986, Apr-15, Volume: 64, Issue:8

    Topics: Administration, Oral; Adult; Antiemetics; Cisplatin; Dose-Response Relationship, Drug; Dronabinol; Humans; Male; Middle Aged; Pyrrolidines; Testicular Neoplasms; Vomiting

1986
Nabilone: an alternative antiemetic for cancer chemotherapy.
    Archives of disease in childhood, 1986, Volume: 61, Issue:5

    Topics: Adolescent; Antiemetics; Antineoplastic Agents; Child; Child, Preschool; Clinical Trials as Topic; Domperidone; Double-Blind Method; Dronabinol; Female; Humans; Infant; Male; Nausea; Random Allocation; Vomiting

1986
Prospective randomized double-blind trial of nabilone versus domperidone in the treatment of cytotoxic-induced emesis.
    Cancer chemotherapy and pharmacology, 1986, Volume: 17, Issue:3

    Topics: Adult; Aged; Antiemetics; Antineoplastic Agents; Domperidone; Double-Blind Method; Dronabinol; Drug Evaluation; Female; Humans; Male; Middle Aged; Prospective Studies; Random Allocation; Vomiting

1986
Stress inoculation training in the control of THC toxicities.
    The International journal of the addictions, 1986, Volume: 21, Issue:8

    Topics: Antineoplastic Agents; Behavior Therapy; Cognition; Dronabinol; Female; Humans; Imagination; Male; Middle Aged; Nausea; Neoplasms; Relaxation Therapy; Stress, Physiological; Vomiting

1986
Nabilone versus prochlorperazine for control of cancer chemotherapy-induced emesis in children: a double-blind, crossover trial.
    Pediatrics, 1987, Volume: 79, Issue:6

    Topics: Adolescent; Antiemetics; Antineoplastic Agents; Child; Child, Preschool; Clinical Trials as Topic; Double-Blind Method; Dronabinol; Humans; Prochlorperazine; Random Allocation; Vomiting

1987
Antiemetic efficacy of nabilone and dexamethasone: a randomized study of patients with lung cancer receiving chemotherapy.
    American journal of clinical oncology, 1987, Volume: 10, Issue:4

    Topics: Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Blood Pressure; Clinical Trials as Topic; Dexamethasone; Double-Blind Method; Dronabinol; Drug Therapy, Combination; Humans; Lung Neoplasms; Nausea; Random Allocation; Vomiting

1987

Other Studies

79 other study(ies) available for dronabinol and Emesis

ArticleYear
Association of Cannabis Use With Nausea and Vomiting of Pregnancy.
    Obstetrics and gynecology, 2022, 08-01, Volume: 140, Issue:2

    Topics: Analgesics; Cannabis; Dronabinol; Female; Gas Chromatography-Mass Spectrometry; Humans; Infant; Nausea; Pregnancy; Substance Abuse Detection; Vomiting

2022
Ultra-low doses of the transient receptor potential vanilloid 1 agonist, resiniferatoxin, prevents vomiting evoked by diverse emetogens in the least shrew (Cryptotis parva).
    Behavioural pharmacology, 2020, Volume: 31, Issue:1

    Topics: Animals; Antiemetics; Diterpenes; Dronabinol; Female; Male; Receptors, Serotonin, 5-HT3; Shrews; TRPV Cation Channels; Vomiting

2020
Cannabis-based medicinal products: summary of NICE guidance.
    BMJ (Clinical research ed.), 2020, Apr-21, Volume: 369

    Topics: Antiemetics; Antineoplastic Agents; Cannabidiol; Cannabinoid Receptor Agonists; Chronic Pain; Decision Making, Shared; Dronabinol; Drug and Narcotic Control; Drug Resistant Epilepsy; Epilepsies, Myoclonic; Humans; Lennox Gastaut Syndrome; Medical Marijuana; Multiple Sclerosis; Muscle Spasticity; Nausea; Needs Assessment; Physicians, Primary Care; Practice Guidelines as Topic; Specialization; United Kingdom; Vomiting

2020
Cannabinoids as antiemetics: everything that's old is new again.
    Annals of oncology : official journal of the European Society for Medical Oncology, 2020, Volume: 31, Issue:11

    Topics: Antiemetics; Antineoplastic Agents; Cannabinoids; Cannabis; Cross-Over Studies; Dronabinol; Humans; Nausea; Plant Extracts; Vomiting

2020
Urinary Cannabis Metabolite Concentrations in Cannabis Hyperemesis Syndrome.
    Journal of pediatric gastroenterology and nutrition, 2021, 10-01, Volume: 73, Issue:4

    Topics: Adolescent; Cannabis; Child; Dronabinol; Humans; Retrospective Studies; Substance Abuse Detection; Vomiting

2021
Cannabinoid Hyperemesis Syndrome Secondary to Delta-8 THC Use.
    The American journal of medicine, 2021, Volume: 134, Issue:12

    Topics: Administration, Cutaneous; Adult; Antiemetics; Cannabinoid Receptor Agonists; Capsaicin; Dopamine Antagonists; Dronabinol; Female; Fluid Therapy; Haloperidol; Humans; Nausea; Sensory System Agents; Vomiting

2021
Availability and approval of cannabis-based medicines for chronic pain management and palliative/supportive care in Europe: A survey of the status in the chapters of the European Pain Federation.
    European journal of pain (London, England), 2018, Volume: 22, Issue:3

    Topics: Antiemetics; Antineoplastic Agents; Cannabidiol; Cannabinoid Receptor Agonists; Chronic Pain; Dronabinol; Drug Approval; Drug Combinations; Europe; Germany; Humans; Israel; Medical Marijuana; Multiple Sclerosis; Muscle Spasticity; Nausea; Pain Management; Palliative Care; Societies, Medical; Surveys and Questionnaires; Vomiting

2018
The Case | Weeding out the cause of acute kidney injury.
    Kidney international, 2017, Volume: 92, Issue:6

    Topics: Acute Kidney Injury; Adult; Creatinine; Dehydration; Dronabinol; Fluid Therapy; Humans; Leukocyte Count; Male; Marijuana Abuse; Oliguria; Vomiting; Weight Loss

2017
Encephalopathy after chocolate consumption.
    The Medical journal of Australia, 2018, 02-19, Volume: 208, Issue:3

    Topics: Adult; Australia; Brain Diseases; Cannabinoids; Chocolate; Dronabinol; Economics; Emergency Service, Hospital; Female; Gait Disorders, Neurologic; Humans; Substance Abuse Detection; Vertigo; Vomiting; Young Adult

2018
Cannabinoid Hyperemesis Syndrome: Reports of Fatal Cases.
    Journal of forensic sciences, 2019, Volume: 64, Issue:1

    Topics: Adult; Baths; Cannabinoids; Chlorides; Creatinine; Dronabinol; Fatal Outcome; Female; Hot Temperature; Humans; Male; Marijuana Abuse; Nausea; Sodium; Urea; Vitreous Body; Vomiting

2019
Increased Use of Medical Marijuana: Skepticism vs. Evidence.
    The Consultant pharmacist : the journal of the American Society of Consultant Pharmacists, 2018, Dec-01, Volume: 33, Issue:12

    Topics: Cannabis; Dronabinol; Humans; Medical Marijuana; Nausea; Pharmacists; United States; Vomiting

2018
Acute Pharmacokinetic Profile of Smoked and Vaporized Cannabis in Human Blood and Oral Fluid.
    Journal of analytical toxicology, 2019, May-01, Volume: 43, Issue:4

    Topics: Adult; Cannabis; Chromatography, Liquid; Double-Blind Method; Dronabinol; Enzyme-Linked Immunosorbent Assay; Female; Hallucinations; Humans; Male; Marijuana Smoking; Osmolar Concentration; Psychotropic Drugs; Saliva; Sensitivity and Specificity; Sex Factors; Substance Abuse Detection; Tandem Mass Spectrometry; Volatilization; Vomiting; Young Adult

2019
Dronabinol Therapy: Central Nervous System Adverse Events in Adults With Primary Brain Tumors.
    Clinical journal of oncology nursing, 2019, 02-01, Volume: 23, Issue:1

    Topics: Adult; Aged; Aged, 80 and over; Antiemetics; Antineoplastic Agents; Brain Neoplasms; Dronabinol; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Nausea; Nervous System; Psychotropic Drugs; Vomiting

2019
Tetrahydrocannabinolic acid reduces nausea-induced conditioned gaping in rats and vomiting in Suncus murinus.
    British journal of pharmacology, 2013, Volume: 170, Issue:3

    Topics: Animals; Antiemetics; Behavior, Animal; Body Temperature Regulation; Brain; Cannabinoid Receptor Antagonists; Disease Models, Animal; Dronabinol; Lithium Chloride; Male; Motor Activity; Nausea; Rats; Rats, Sprague-Dawley; Receptor, Cannabinoid, CB1; Shrews; Time Factors; Vomiting

2013
Dronabinol treatment of refractory nausea and vomiting related to peritoneal carcinomatosis.
    The American journal of hospice & palliative care, 2015, Volume: 32, Issue:1

    Topics: Antiemetics; Carcinoma; Dronabinol; Female; Humans; Middle Aged; Nausea; Ovarian Neoplasms; Peritoneal Neoplasms; Vomiting

2015
Additive antiemetic efficacy of low-doses of the cannabinoid CB(1/2) receptor agonist Δ(9)-THC with ultralow-doses of the vanilloid TRPV1 receptor agonist resiniferatoxin in the least shrew (Cryptotis parva).
    European journal of pharmacology, 2014, Jan-05, Volume: 722

    Topics: Animals; Antiemetics; Cannabinoid Receptor Agonists; Capsaicin; Cisplatin; Diterpenes; Dose-Response Relationship, Drug; Dronabinol; Drug Synergism; Female; Male; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2; Ruthenium Red; Shrews; TRPV Cation Channels; Vomiting

2014
[No opiates against cannabis hyperemesis syndrome].
    Deutsche medizinische Wochenschrift (1946), 2014, Volume: 139, Issue:8

    Topics: Adult; Antiemetics; Dronabinol; Drug Administration Schedule; Drug Resistance; Drug Therapy, Combination; Germany; Humans; Infusions, Intravenous; Male; Marijuana Abuse; Methadone; Morphine; Opioid-Related Disorders; Substance Abuse Treatment Centers; Substance Withdrawal Syndrome; Vomiting

2014
Nabilone therapy for cannabis withdrawal presenting as protracted nausea and vomiting.
    BMJ case reports, 2014, Sep-22, Volume: 2014

    Topics: Cannabinoids; Cannabis; Diagnosis, Differential; Dronabinol; Female; Humans; Nausea; Substance Withdrawal Syndrome; Vomiting; Young Adult

2014
Synergy between cannabidiol, cannabidiolic acid, and Δ⁹-tetrahydrocannabinol in the regulation of emesis in the Suncus murinus (house musk shrew).
    Behavioral neuroscience, 2015, Volume: 129, Issue:3

    Topics: Animals; Antiemetics; Cannabidiol; Cannabinoids; Disease Models, Animal; Dronabinol; Drug Therapy, Combination; Female; Lithium Chloride; Male; Shrews; Vomiting

2015
Delta 9-tetrahydrocannabinol suppresses vomiting behavior and Fos expression in both acute and delayed phases of cisplatin-induced emesis in the least shrew.
    Behavioural brain research, 2009, Jan-03, Volume: 196, Issue:1

    Topics: Analgesics, Non-Narcotic; Animals; Area Postrema; Brain Stem; Cisplatin; Dronabinol; Drug Therapy, Combination; Female; Immunohistochemistry; Injections, Intraperitoneal; Microscopy, Confocal; Neurons; Oncogene Proteins v-fos; Piperidines; Presynaptic Terminals; Pyrazoles; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2; Rimonabant; Serotonin; Shrews; Solitary Nucleus; Substance P; Time Factors; Vomiting

2009
The antiemetic interaction of Delta9-tetrahydrocannabinol when combined with tropisetron or dexamethasone in the least shrew.
    Pharmacology, biochemistry, and behavior, 2009, Volume: 91, Issue:3

    Topics: Animals; Antiemetics; Antineoplastic Agents; Cisplatin; Dexamethasone; Dose-Response Relationship, Drug; Dronabinol; Female; Indoles; Male; Shrews; Tropisetron; Vomiting

2009
The effects of cannabidiol and tetrahydrocannabinol on motion-induced emesis in Suncus murinus.
    Basic & clinical pharmacology & toxicology, 2008, Volume: 103, Issue:2

    Topics: Animals; Antiemetics; Cannabidiol; Disease Models, Animal; Dose-Response Relationship, Drug; Dronabinol; Motion Sickness; Receptor, Cannabinoid, CB1; Shrews; Vestibule, Labyrinth; Vomiting

2008
[Cannabinoid hyperemesis].
    Medicina clinica, 2011, May-21, Volume: 136, Issue:14

    Topics: Dronabinol; Humans; Male; Marijuana Abuse; Vomiting; Young Adult

2011
[Cannabinoid hyperemesis syndrome inducing acute prerenal failure and electrolyte disturbance].
    Deutsche medizinische Wochenschrift (1946), 2011, Volume: 136, Issue:34-35

    Topics: Acute Kidney Injury; Adult; Diagnosis, Differential; Dronabinol; Humans; Kidney Function Tests; Male; Marijuana Abuse; Psychotropic Drugs; Schizophrenia, Paranoid; Vomiting; Water-Electrolyte Imbalance

2011
[Medical applications of dronabinol].
    Medizinische Monatsschrift fur Pharmazeuten, 2002, Volume: 25, Issue:11

    Topics: Antiemetics; Dronabinol; Drug Interactions; Humans; Receptors, Cannabinoid; Receptors, Drug; Vomiting

2002
Antiemetic and motor-depressive actions of CP55,940: cannabinoid CB1 receptor characterization, distribution, and G-protein activation.
    European journal of pharmacology, 2003, Jan-10, Volume: 459, Issue:1

    Topics: Animals; Antiemetics; Benzoxazines; Binding, Competitive; Brain; Cisplatin; Cyclohexanols; Dose-Response Relationship, Drug; Dronabinol; Female; GTP-Binding Proteins; Guanosine 5'-O-(3-Thiotriphosphate); Injections, Intraperitoneal; Injections, Subcutaneous; Male; Morpholines; Motor Activity; Naphthalenes; Piperidines; Pyrazoles; Radioligand Assay; Receptors, Cannabinoid; Receptors, Drug; Rimonabant; Shrews; Sulfur Radioisotopes; Tritium; Vomiting

2003
Delta9-tetrahydrocannabinol selectively acts on CB1 receptors in specific regions of dorsal vagal complex to inhibit emesis in ferrets.
    American journal of physiology. Gastrointestinal and liver physiology, 2003, Volume: 285, Issue:3

    Topics: Animals; Antiemetics; Area Postrema; Cisplatin; Dronabinol; Ferrets; Medulla Oblongata; Proto-Oncogene Proteins c-fos; Receptors, Cannabinoid; Receptors, Drug; Tissue Distribution; Vagus Nerve; Vomiting

2003
Effect of cannabinoids on lithium-induced vomiting in the Suncus murinus (house musk shrew).
    Psychopharmacology, 2004, Volume: 171, Issue:2

    Topics: Animals; Antiemetics; Cannabidiol; Dose-Response Relationship, Drug; Dronabinol; Female; Injections, Intraperitoneal; Lithium Chloride; Male; Piperidines; Pyrazoles; Rimonabant; Shrews; Vomiting

2004
A comparative analysis of the potential of cannabinoids and ondansetron to suppress cisplatin-induced emesis in the Suncus murinus (house musk shrew).
    Psychopharmacology, 2004, Volume: 174, Issue:2

    Topics: Animals; Antiemetics; Antineoplastic Agents; Cannabinoids; Cisplatin; Dose-Response Relationship, Drug; Dronabinol; Drug Therapy, Combination; Female; Lithium; Male; Ondansetron; Piperidines; Psychotropic Drugs; Pyrazoles; Rimonabant; Shrews; Vomiting

2004
Delta-9-tetrahydrocannabinol differentially suppresses emesis versus enhanced locomotor activity produced by chemically diverse dopamine D2/D3 receptor agonists in the least shrew (Cryptotis parva).
    Pharmacology, biochemistry, and behavior, 2005, Volume: 80, Issue:1

    Topics: Animals; Dopamine Agonists; Dose-Response Relationship, Drug; Dronabinol; Female; Male; Receptors, Dopamine D2; Receptors, Dopamine D3; Shrews; Vomiting

2005
Ondansetron and Delta-9-tetrahydrocannabinol interfere with the establishment of lithium-induced conditioned taste avoidance in the house musk shrew (Suncus murinus).
    Behavioral neuroscience, 2005, Volume: 119, Issue:4

    Topics: Analgesics, Non-Narcotic; Analysis of Variance; Animals; Avoidance Learning; Behavior, Animal; Dose-Response Relationship, Drug; Dronabinol; Drug Interactions; Female; Lithium; Male; Ondansetron; Saccharin; Serotonin Antagonists; Shrews; Sweetening Agents; Taste; Vomiting

2005
Receptor mechanism and antiemetic activity of structurally-diverse cannabinoids against radiation-induced emesis in the least shrew.
    European journal of pharmacology, 2007, Jun-01, Volume: 563, Issue:1-3

    Topics: Animals; Antiemetics; Benzoxazines; Cannabinoids; Cyclohexanols; Disease Models, Animal; Dose-Response Relationship, Drug; Dose-Response Relationship, Radiation; Dronabinol; Gamma Rays; Locomotion; Morpholines; Naphthalenes; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2; Shrews; Vomiting

2007
Nabilone in the management of prochlorperazine resistant cancer chemotherapy induced emesis.
    Irish medical journal, 1984, Volume: 77, Issue:9

    Topics: Antineoplastic Agents; Dronabinol; Humans; Nausea; Prochlorperazine; Vomiting

1984
Antiemetics.
    British journal of hospital medicine, 1984, Volume: 32, Issue:2

    Topics: Age Factors; Aged; Antiemetics; Cisplatin; Dronabinol; Humans; Metoclopramide; Vomiting

1984
Cannabis: a medical question?
    Lancet (London, England), 1980, Mar-29, Volume: 1, Issue:8170

    Topics: Antineoplastic Agents; Dronabinol; Humans; Neoplasms; Vomiting

1980
[Vomiting accompanying cytostatic treatment, and its control].
    Polski tygodnik lekarski (Warsaw, Poland : 1960), 1984, Nov-19, Volume: 39, Issue:47

    Topics: Antiemetics; Antineoplastic Agents; Dronabinol; Drug Evaluation; Histamine H1 Antagonists; Humans; Metoclopramide; Neoplasms; Prochlorperazine; Vomiting

1984
delta 9-Tetrahydrocannabinol for refractory vomiting induced by cancer chemotherapy.
    JAMA, 1980, Mar-28, Volume: 243, Issue:12

    Topics: Adult; Antineoplastic Agents; Dronabinol; Humans; Nausea; Vomiting

1980
Marijuana for drug-induced nausea and vomiting.
    JAMA, 1980, Mar-28, Volume: 243, Issue:12

    Topics: Antineoplastic Agents; Dronabinol; Humans; Nausea; Vomiting

1980
Tetrahydrocannabinol as an antiemetic for cancer patients.
    Wisconsin medical journal, 1980, Volume: 79, Issue:3

    Topics: Antiemetics; Dronabinol; Kinetics; Nausea; Neoplasms; Vomiting

1980
Marihuana for nausea and vomiting due to cancer chemotherapy.
    The Medical letter on drugs and therapeutics, 1980, May-16, Volume: 22, Issue:10

    Topics: Dronabinol; Drug-Related Side Effects and Adverse Reactions; Humans; Nausea; Neoplasms; Prochlorperazine; Vomiting

1980
Marijuana for nausea and vomiting in cancer patients.
    Journal of the Medical Association of Georgia, 1980, Volume: 69, Issue:11

    Topics: Antineoplastic Agents; Cannabinoids; Cannabis; Dronabinol; Humans; Nausea; Neoplasms; Vomiting

1980
Nabilone and cancer chemotherapy.
    Annals of internal medicine, 1982, Volume: 96, Issue:1

    Topics: Antiemetics; Antineoplastic Agents; Dronabinol; Humans; Nausea; Vomiting

1982
[Pharmacotherapy of emesis caused by cytostatic agents].
    Nederlands tijdschrift voor geneeskunde, 1982, May-01, Volume: 126, Issue:18

    Topics: Antiemetics; Antineoplastic Agents; Domperidone; Dronabinol; Humans; Metoclopramide; Phenothiazines; Vomiting

1982
Anticipatory nausea and vomiting associated with cancer chemotherapy.
    The New England journal of medicine, 1982, Sep-23, Volume: 307, Issue:13

    Topics: Antiemetics; Antineoplastic Agents; Dronabinol; Humans; Nausea; Vomiting

1982
delta 9-Tetrahydrocannabinol and therapeutic research legislation for cancer patients.
    JAMA, 1983, Mar-18, Volume: 249, Issue:11

    Topics: Antineoplastic Agents; Dronabinol; Humans; Legislation, Drug; National Health Programs; National Institutes of Health (U.S.); Nausea; Neoplasms; United States; United States Food and Drug Administration; Vomiting; Wisconsin

1983
Nabilone: an effective antiemetic agent in patients receiving cancer chemotherapy.
    Cancer treatment reviews, 1982, Volume: 9 Suppl B

    Topics: Antiemetics; Antineoplastic Agents; Blood Pressure; Dronabinol; Humans; Nausea; Prochlorperazine; Vomiting

1982
Use of nabilone in the treatment of chemotherapy-induced vomiting in an outpatient setting.
    Cancer treatment reviews, 1982, Volume: 9 Suppl B

    Topics: Ambulatory Care; Antiemetics; Antineoplastic Agents; Dronabinol; Humans; Vomiting

1982
Cannabis: finally a therapeutic agent?
    Drug and alcohol dependence, 1983, Volume: 11, Issue:2

    Topics: Animals; Antineoplastic Agents; Asthma; Dronabinol; Glaucoma; Humans; Hypertension; Nociceptors; Seizures; Sensory Thresholds; Sleep Initiation and Maintenance Disorders; Spasm; Vomiting

1983
Levonantradol: a synthetic cannabinoid in the treatment of severe chemotherapy-induced nausea and vomiting resistant to conventional anti-emetic therapy.
    Clinical oncology, 1983, Volume: 9, Issue:2

    Topics: Adult; Aged; Antiemetics; Antineoplastic Agents; Dronabinol; Female; Humans; Male; Middle Aged; Nausea; Phenanthridines; Vomiting

1983
[A marihuana component for nausea and vomiting induced by chemo- and radiotherapy].
    Harefuah, 1983, Nov-15, Volume: 105, Issue:10

    Topics: Antiemetics; Antineoplastic Agents; Dronabinol; Humans; Nausea; Neoplasms; Prospective Studies; Vomiting

1983
An initial evaluation of Nabilone in the control of radiotherapy-induced nausea and vomiting.
    Clinical radiology, 1984, Volume: 35, Issue:4

    Topics: Adult; Antiemetics; Dronabinol; Female; Humans; Male; Metoclopramide; Middle Aged; Nausea; Radiotherapy; Vomiting

1984
Marijuana as an antiemetic drug: how useful is it today? Opinions from clinical oncologists.
    Journal of addictive diseases, 1994, Volume: 13, Issue:1

    Topics: Administration, Oral; Adult; Antiemetics; Antineoplastic Agents; Attitude of Health Personnel; Dronabinol; Drug Approval; Humans; Marijuana Smoking; Nausea; Neoplasms; Patient Care Team; Treatment Outcome; Vomiting

1994
The medical use of marijuana: the case for clinical trials.
    Journal of addictive diseases, 1995, Volume: 14, Issue:1

    Topics: Clinical Trials as Topic; Dronabinol; Drug and Narcotic Control; Drug Prescriptions; Humans; Marijuana Smoking; Nausea; Neoplasms; Palliative Care; Treatment Outcome; United States; Vomiting

1995
Cannabis as a medicine?
    British journal of anaesthesia, 1995, Volume: 74, Issue:4

    Topics: Animals; Cannabis; Dronabinol; Female; Fetal Growth Retardation; Humans; Nausea; Pain; Pregnancy; Schizophrenia; Vomiting

1995
Effect of nabilone on nausea and vomiting.
    British journal of anaesthesia, 1995, Volume: 74, Issue:1

    Topics: Antiemetics; Dronabinol; Humans; Postoperative Complications; Vomiting

1995
Medicinal use of marijuana.
    The American journal of nursing, 1997, Volume: 97, Issue:11

    Topics: Acquired Immunodeficiency Syndrome; Antineoplastic Agents; Cannabis; Dronabinol; Humans; Nausea; Neoplasms; Phytotherapy; Vomiting

1997
Intractable nausea and vomiting due to gastrointestinal mucosal metastases relieved by tetrahydrocannabinol (dronabinol).
    Journal of pain and symptom management, 1997, Volume: 14, Issue:5

    Topics: Antiemetics; Dronabinol; Gastric Mucosa; Gastrointestinal Neoplasms; Humans; Intestinal Mucosa; Male; Middle Aged; Nausea; Vomiting

1997
Survey research vs clinical trials in evaluating the medical utility of marijuana.
    Southern medical journal, 1998, Volume: 91, Issue:10

    Topics: Antiemetics; Cannabis; Clinical Trials as Topic; Dronabinol; Health Surveys; Humans; Marijuana Smoking; Medical Oncology; Nausea; Phytotherapy; Practice Patterns, Physicians'; Research; Vomiting

1998
Delta(9)-tetrahydrocannabinol and synthetic cannabinoids prevent emesis produced by the cannabinoid CB(1) receptor antagonist/inverse agonist SR 141716A.
    Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2001, Volume: 24, Issue:2

    Topics: Analgesics, Non-Narcotic; Animals; Cannabinoids; Dronabinol; Female; Male; Piperidines; Pyrazoles; Receptors, Cannabinoid; Receptors, Drug; Rimonabant; Shrews; Vomiting

2001
[Therapy of vomiting due to cytostatic treatment].
    MMW, Munchener medizinische Wochenschrift, 1979, Nov-02, Volume: 121, Issue:44

    Topics: Antiemetics; Antineoplastic Agents; Antipsychotic Agents; Autogenic Training; Dronabinol; Humans; Hypnosis; Phenobarbital; Vomiting

1979
Antagonism of cisplatin induced emesis in the dog.
    Research communications in chemical pathology and pharmacology, 1979, Volume: 23, Issue:1

    Topics: Animals; Antiemetics; Chlorpromazine; Cisplatin; Dogs; Dronabinol; Female; Haloperidol; Indoles; Male; Metoclopramide; Piperidines; Vomiting

1979
Cannabis and cancer chemotherapy.
    Annals of internal medicine, 1979, Volume: 90, Issue:2

    Topics: Antiemetics; Antineoplastic Agents; Dronabinol; Humans; Nausea; Neoplasms; Vomiting

1979
Suppression of cancer chemotherapy-induced vomiting in the cat by nabilone, a synthetic cannabinoid.
    Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.), 1979, Volume: 160, Issue:4

    Topics: Animals; Antiemetics; Antineoplastic Agents; Apomorphine; Behavior, Animal; Cats; Deslanoside; Dronabinol; Nicotine; Vomiting

1979
Cannabinoids and emesis.
    The New England journal of medicine, 1978, Jun-29, Volume: 298, Issue:26

    Topics: Animals; Antiemetics; Antineoplastic Agents; Cats; Dronabinol; Prochlorperazine; Vomiting

1978
Potential therapeutic applications of naturally occurring and synthetic cannabinoids.
    General pharmacology, 1978, Volume: 9, Issue:4

    Topics: Alcoholism; Animals; Appetite; Asthma; Cannabinoids; Cough; Depression; Diarrhea; Dronabinol; Epilepsy; Glaucoma; Humans; Hypertension; Narcotics; Neoplasms; Pain; Parasympatholytics; Substance-Related Disorders; Vomiting

1978
Marijuana. Does it have a possible therapeutic use?
    JAMA, 1978, Oct-13, Volume: 240, Issue:16

    Topics: Asthma; Cannabinoids; Cannabis; Depression; Dronabinol; Drug Stability; Epilepsy; Glaucoma; Humans; Pain; Vomiting

1978
Side effects of simultaneous alcohol and marijuana use.
    The American journal of psychiatry, 1977, Volume: 134, Issue:6

    Topics: Adult; Autonomic Nervous System; Blood Pressure; Dose-Response Relationship, Drug; Dronabinol; Ethanol; Heart Rate; Humans; Male; Nausea; Placebos; Vomiting

1977
Letter: Tetrahydrocannabinol and chemotherapy.
    The New England journal of medicine, 1976, Jan-15, Volume: 294, Issue:3

    Topics: Adult; Bone Neoplasms; Cannabis; Dronabinol; Female; Humans; Hyperalgesia; Hyperesthesia; Leukemia, Myeloid, Acute; Male; Pain; Phytotherapy; Vomiting

1976
Marijuana as medicine.
    The Medical journal of Australia, 1992, Apr-06, Volume: 156, Issue:7

    Topics: Antineoplastic Agents; Cannabinoids; Cannabis; Dronabinol; Humans; Marijuana Smoking; Vomiting

1992
Nabilone for the management of intractable nausea and vomiting in terminally staged AIDS.
    Journal of palliative care, 1992,Summer, Volume: 8, Issue:2

    Topics: Acquired Immunodeficiency Syndrome; Adult; Antiemetics; Dronabinol; Humans; Male; Nausea; Pneumonia, Pneumocystis; Terminal Care; Vomiting

1992
Case report: the effect of tetrahydrocannabinol on food intake during chemotherapy.
    Journal of the American College of Nutrition, 1990, Volume: 9, Issue:6

    Topics: Antineoplastic Combined Chemotherapy Protocols; Appetite; Dronabinol; Eating; Energy Intake; Hodgkin Disease; Humans; Male; Middle Aged; Nausea; Vomiting

1990
Psychoactive cannabinoids reduce gastrointestinal propulsion and motility in rodents.
    The Journal of pharmacology and experimental therapeutics, 1989, Volume: 249, Issue:2

    Topics: Analgesia; Animals; Cannabinoids; Cannabinol; Depression, Chemical; Dronabinol; Gastric Emptying; Gastrointestinal Motility; Male; Mice; Mice, Inbred ICR; Nausea; Rats; Rats, Inbred Strains; Vomiting

1989
Nabilone as effective therapy for intractable nausea and vomiting in AIDS.
    British journal of clinical pharmacology, 1989, Volume: 28, Issue:4

    Topics: Acquired Immunodeficiency Syndrome; Dronabinol; Humans; Male; Middle Aged; Nausea; Vomiting

1989
Inhibition of cisplatin-induced emesis in the pigeon by a non-psychotropic synthetic cannabinoid.
    European journal of pharmacology, 1989, Oct-04, Volume: 169, Issue:1

    Topics: Animals; Antiemetics; Cannabinoids; Cisplatin; Columbidae; Copper; Dronabinol; Female; Male; Vomiting

1989
Dronabinol and nabilone ease cancer chemotherapy.
    Nursing, 1988, Volume: 18, Issue:8

    Topics: Antiemetics; Antineoplastic Agents; Dronabinol; Humans; Nausea; Vomiting

1988
Therapeutic issues of marijuana and THC (tetrahydrocannabinol).
    The International journal of the addictions, 1985, Volume: 20, Issue:5

    Topics: Antineoplastic Agents; Anxiety; Bronchial Spasm; Cannabis; Dronabinol; Glaucoma; Humans; Muscle Spasticity; Nausea; Pain; Sleep Initiation and Maintenance Disorders; Vomiting

1985
Pharmacology. Counteracting side-effects.
    Nursing mirror, 1985, Oct-02, Volume: 161, Issue:14

    Topics: Antineoplastic Agents; Dronabinol; Humans; Nausea; Vomiting

1985
Synthetic marijuana for nausea and vomiting due to cancer chemotherapy.
    The Medical letter on drugs and therapeutics, 1985, Nov-22, Volume: 27, Issue:701

    Topics: Antiemetics; Antineoplastic Agents; Dronabinol; Humans; Nausea; Vomiting

1985
The antiemetic effect of Cannabis sativa during cytotoxic therapy.
    South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde, 1985, Nov-23, Volume: 68, Issue:11

    Topics: Antineoplastic Agents; Chlorpromazine; Dronabinol; Humans; Vomiting

1985